Kimia Biosciences Quarterly Results for Trading Insights

KIMIABL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹10 Cr
QMarch 2025
Quarterly Results

Kimia Biosciences Quarterly Results Key Highlights

  • Revenue of ₹120 Cr in March 2025 (+0.0% vs March 2025, +12.1% vs March 2024)
  • Net Profit of ₹10 Cr in March 2025 (+0.0% vs March 2025, +300.0% vs March 2024)
  • EBITDA of ₹22 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 17.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹2.03 in March 2025 (+0.0% vs March 2025)

Kimia Biosciences Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 127 120 107 130 126 5.8% -
Net Profit (₹ Cr) 8 10 -5 -9 -4 - -
EBITDA (₹ Cr) 20 22 1 -4 2 - -
EPS (₹) 1.70 2.03 -1.12 -1.98 -0.78 - -
Operating Margin (%) 14.0% 17.0% 0.0% -4.0% 1.0% - -

Kimia Biosciences Share Price Trend Around Quarterly Results

Visualize Kimia Biosciences's 1-year price movement across quarterly results — ideal for logging trades in Kimia Biosciences share price chart using Tickjournal. All values in ₹.

Related Pages for Kimia Biosciences

Additional stock information and data for KIMIABL

Kimia Biosciences networth
Kimia Biosciences intrinsic price
Kimia Biosciences dividend payments
KIMIABL stock price chart
KIMIABL share price data
KIMIABL ownership pattern
KIMIABL DCF
KIMIABL P/E ratio

Profitability Ratios

Profit Margin 8.3%
EBITDA Margin 18.3%
Operating Margin 17.0%
ROE (Annual) 100.0%

Balance Sheet Highlights

Total Assets ₹111 Cr
Total Equity ₹10 Cr
Current Assets ₹75 Cr
Current Liabilities ₹19 Cr

Cash Flow Analysis

Operating Cash Flow ₹21 Cr
Investing Cash Flow ₹-5 Cr
Financing Cash Flow ₹-17 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹32.25
Exchange BSE
Last Updated Jan 09, 2026

Revenue Trend (₹ Cr)

March 2023 130
March 2024 107
March 2025 120
2026 127

Net Profit Trend (₹ Cr)

March 2023 -9
March 2024 -5
March 2025 10
2026 8

Operating Margin Trend (%)

March 2023 -4.0%
March 2024 0.0%
March 2025 17.0%
2026 14.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Kimia Biosciences quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹417,052.40 Cr 1729.9 14,875 3,125 +10.8% - 21.0% 133.1
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6616.5 2,860 689 +7.1% - 24.1% 254.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 3963.4 3,219 591 +11.3% - 18.4% 226.0
Cipla
Sept 2025 		₹118,572.82 Cr 1465.7 7,716 1,353 +12.0% - 17.5% 87.6
Dr Reddys Laborator…
Sept 2025 		₹100,998.62 Cr 1210.1 9,135 1,337 +1.1% - 14.6% 74.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores